HARNESSING SYNERGIES BETWEEN 177LUTATE THERAPY AND OLAPARIB TO IMPROVE CLINICAL OUTCOME OF MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER

Grant number: 17CHAL09 | Funding period: 2017 - 2021

Active